More News

Promising data from acute myeloid leukaemia trial

Thalia Therapeutics plc has announced promising interim data from its phase I clinical trial in acute myeloid leukaemia (AML)...

Sofinnova Partners closes €725m Crossover II Fund

Sofinnova Partners has announced the final close of Sofinnova Crossover II at €725m. The fund exceeded its original target, reflecting...

ALS data revealed at Neuroscience 2026

Axoltis Pharma has announced additional data and analyses from SEALS, its phase 2 clinical trial evaluating NX210c in patients...

Small RNA from surrounding cells promotes triple negative breast cancer growth

Triple-negative breast cancer, which accounts for approximately 10–15% of all breast cancer cases, is considered particularly difficult to treat...

Blood test could track small-cell lung cancer

A new study shows how a blood sample could help doctors track an aggressive form of lung cancer and...

Base to Base biotech podcast 84: 3D printing and secretomes

This week, we have a conversation with Dylan Yeo, CEO and co-founder of Klona Biotech about 3D printing of...

Partnership to discover small-molecule therapeutics

DeepLife, a Paris-based techbio company developing AI-powered digital twins of human cells, and 3billion, an AI-powered genomics company specialising...

New Sjögren’s disease study data

Johnson & Johnson has announced new patient experience findings from the phase 2 DAHLIAS study of nipocalimab in Sjögren's...

Macrophage activation syndrome study data published

TJ Biopharma has announced the publication of results from PRIME-1, a phase 2 study of plonmarlimab in macrophage activation...

European patent for fibroblast delivery of tumour inhibitory agents

FibroBiologics, Inc. has announced that the European Patent Office has granted European Patent "Fibroblast Delivery of Tumor Inhibitory Agents." The...

Obesity drugs could lead to new ways to protect the brain

Drugs used to treat obesity may also help protect the brain. In a review published in Science, researchers describe...

Data support bladder-preserving alternative to radical cystectomy

Combat Medical has announced new data showing 68% high-grade recurrence-free survival (HG-RFS) at 12 months in patients with Bacillus...

Molecular switch triggers inflammation

Researchers at VIB and Ghent University have uncovered how an important driver of inflammation is activated at the molecular...

Shilpa CDMO to invest $50m in commercial peptide manufacturing

Shilpa CDMO is investing $50m to expand its peptide manufacturing capabilities as global demand accelerates for GLP-1s and a...

Unnatural Products to be acquired by argenx in $1.15bn deal

Unnatural Products, Inc. (UNP), a biotech developing orally-delivered macrocyclic peptides to address previously undruggable targets, has entered into a...

“Significant improvement” in psoriatic arthritis disease activity with oral peptide

Johnson & Johnson has announced positive results from a phase 3 study investigating ICOTYDE (icotrokinra) in biologic-naïve adults with...

Is synthetic DNA tomorrow’s hard drive?

Every day we generate enormous amounts of data. And the rise of artificial intelligence has increased that output. The question...

Base to Base biotech podcast 83: Different approaches to beating cancer tumours

This week, we have a conversation with Valerie Vanhooren, CEO and co-founder of Ona Therapeutics about first-in-class ADCs for...

Data for MDM2 inhibitor announced

Lamassu Biotech has announced initial safety and pharmacokinetic data from the ongoing first-in-human phase 1/2a clinical trial (LB-SA53-101) of...

Transpharmation acquiring OrganoTherapeutics

Transpharmation Ltd. has announced the acquisition of OrganoTherapeutics SARL, a provider of patient-derived organoid technologies that advance the discovery...

Astrosalva Therapeutics born to beat Alexander disease and cALD

Astrosalva Therapeutics, Inc. has launched to develop treatments for Alexander disease and the cerebral form of adrenoleukodystrophy (cALD). Unravel Biosciences,...